SUTRO BIOPHARMA, INC. (STRO) Operating income 2016–2025
SUTRO BIOPHARMA, INC. (STRO) annual operating income history from SEC filings — each fiscal year as reported.
-$158.4MFY2025 · since FY2016: $1.4M → -$158.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$158.4M | +33.6% |
| FY2024 | -$238.5M | -167.1% |
| FY2023 | -$89.3M | +30.8% |
| FY2022 | -$128.9M | -30.9% |
| FY2021 | -$98.5M | -38.7% |
| FY2020 | -$71.1M | -28.1% |
| FY2019 | -$55.5M | -49.0% |
| FY2018 | -$37.2M | -93.1% |
| FY2017 | -$19.3M | -1512.9% |
| FY2016 | $1.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More STRO financial trends
STRO RevenueSTRO Net incomeSTRO Net marginSTRO Gross profitSTRO Gross marginSTRO Operating marginSTRO Operating cash flowSTRO Free cash flowSTRO Capital expendituresSTRO Return on equitySTRO Stock buybacksSTRO Dividends paidSTRO Total assetsSTRO Total liabilitiesSTRO Shareholders’ equitySTRO overview →